CollPlant Biotechnologies Ltd (CLGN) stock
CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI
$3.96+0.06 (+1.54%)
Close on Nov 11, 2026Market cap –P/E –Yield –
CollPlant Biotechnologies profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -484.6%, against -3225.0% the year before. The highest annual figure on record is 1.5% in fiscal 2021.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -484.6% | +2740.5 |
| FY2024 | Dec 31, 2024 | -3225.0% | −3161.0 |
| FY2023 | Dec 31, 2023 | -64.0% | +5596.5 |
| FY2022 | Dec 31, 2022 | -5660.5% | −5662.1 |
| FY2021 | Dec 31, 2021 | 1.5% | +95.6 |
| FY2020 | Dec 31, 2020 | -94.1% | +387.5 |
| FY2019 | Dec 31, 2019 | -481.6% | −357.0 |
| FY2018 | Dec 31, 2018 | -124.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -1869.8% | −1430.2 |
| Q2 FY2024 | Jun 30, 2024 | -1690.8% | −1451.3 |
| Q2 FY2023 | Jun 30, 2023 | 56.6% | +262.5 |
| Q2 FY2022 | Jun 30, 2022 | -6492.4% | – |
| Q2 FY2021 | Jun 30, 2021 | -439.7% | – |
| Q2 FY2020 | Jun 30, 2020 | -239.5% | – |
| Q2 FY2019 | Jun 30, 2019 | -205.9% | – |
See a number that looks wrong?